A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).
about
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerDevelopment of the external genitalia: perspectives from the spotted hyena (Crocuta crocuta)Effects of long-term flutamide treatment during development in zebra finchesIsoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice.Administration of tamoxifen but not flutamide to hormonally intact, adult male rats mimics the effects of short-term gonadectomy on the catecholamine innervation of the cerebral cortex.Hormonal therapy for stage D cancer of the prostateDose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice.Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.Towards a rational terminology in the study of the gubernaculum testis: arguments in support of the notion that the cremasteric sac should be considered the gubernaculum in postnatal rats and other mammals.Research on reproductive medicine in the pharmaceutical industry.Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidismSteroid hormone agonists and antagonists in the treatment of cancer.5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.Androgen receptors, sex behavior, and aggression.Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.Prostatic adenocarcinoma. Carcinogenesis and growth.Mechanistic approaches in the study of testicular toxicity: toxicants that affect the endocrine regulation of the testis.Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss.The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.Effect of antiandrogen flutamide on measures of hepatic regeneration in rats.Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).Combination therapy in prostate cancer.The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein.Androgen-induced cell growth and c-myc expression in human non-transformed epithelial prostatic cells in primary culture.Antiandrogen blocks estrogen-induced masculinization of the song system in female zebra finches.Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study.Expression of aquaporin 9 in the adult rat epididymal epithelium is modulated by androgens.Ovarian hormones after postnatal day 20 reduce neuron number in the rat primary visual cortex.The influence of the antiandrogen 2-hydroxyflutamide on the androgen receptor expression in the porcine ovarian follicles - an in vitro study.Prenatal androgen-receptor activity has organizational morphological effects in mice.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.Prenatal androgen receptor activation determines adult alcohol and water drinking in a sex-specific way.Antiandrogenic potency of drugs, evaluated by urinary enzyme excretion technique.Flutamide in the treatment of hirsutism.Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period.Treatment of hyperandrogenism in womenOvulatory effects of flutamide in the polycystic ovary syndrome
P2860
Q26750620-3C982897-96D9-4F29-9924-6A7AE6842D81Q28657729-C9402CE5-EAFA-4A91-9908-270FBD7079FFQ28756068-DEA2062F-7988-4722-B8E0-EE9E434D66DDQ30495519-0525303E-626C-43A9-9E8F-14B60542E1BFQ32063400-AB078DDF-6538-47F8-981B-626CE4CCEF01Q33607710-DD78A5B3-F68C-4AD8-B4FF-953BD7DD99CAQ33652531-513D658C-7960-4781-B793-4DF500C7A82BQ33765455-82B2DF35-9F9F-4038-A472-8D62DAA4D7D0Q33882353-9A16F207-E39E-4A6E-9872-2C28D556F792Q34114028-56D744FC-065B-455C-A905-5D22C2967C6AQ34388347-C59DD3B0-E337-48EE-95F1-8AF0E26A04C1Q34751984-571AB0B0-EC2C-4362-A756-4D550C8FA94AQ34761697-C1DC1443-F2ED-4502-BC30-DE7D41E679E2Q35309303-C44E1B18-CC69-471E-9169-3BFA74CDB4DFQ36080636-54D37BBC-2F3B-40BA-ABA1-125B8C3E8D08Q36326556-D5AB5845-797E-46AE-8876-308FB354AD0DQ37380071-B22E8160-8275-45B9-A042-279C7D43A7A2Q38535009-DBEA30BE-06CE-4388-B9BA-9D2BB2C573B6Q38692448-6DD8FB45-9B68-4B3A-A2F6-B7D88111EB85Q39205338-DCA83C27-BA1C-4D50-B33D-3EC332ABFC66Q41054374-B953CAC0-D099-4BF6-B11D-A9A66F528299Q42410329-83A79BD0-3656-4E49-812C-5B14C9653284Q42463314-A3ECDBA8-6732-4E73-A0DB-EDA77265C8AAQ43051348-93BD2A3A-38C2-437C-ABDC-C5AC94FDF23BQ43175790-35C46BF8-BC54-46DA-B097-88B936584EBFQ43615480-89B95F4D-A20A-4A00-A57E-5470D0A31FBCQ43655147-EDB03E12-F911-4142-A52E-264DE59B27C1Q43938142-C699E8D3-0C18-4AAE-966C-925773D68F01Q43969598-B2B65150-AFED-4ADC-A6C6-6CBF35484AFFQ44000505-723E0AF4-ADE4-409D-97AB-25838277B6D9Q44124511-BAE440CB-5955-40AD-85B5-4C9998186984Q45350391-99863F71-8568-4025-BC06-D26B6BA3C241Q47142960-8A4B1813-6D47-44B2-AF91-2F5CF6D0E588Q47825566-F701909C-EC30-413D-82B7-9E97692DCC12Q47942495-4C4EDAA1-F2CF-43EE-AB09-5A8B4DF9E805Q53704018-85900738-6F7D-40CF-9A10-9C2457B29BBBQ55042187-C1244F0D-054A-48BD-8CE2-391897D99CC2Q55053646-8799F4E6-200E-459C-9120-7138C5B9286CQ55892518-FBAF5293-DCBC-40DD-9C6D-CF43264399BFQ56978708-573A458A-5EEF-41D8-845C-4C2D51653623
P2860
A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@en
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@nl
type
label
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@en
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@nl
prefLabel
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@en
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@nl
P2093
P356
P1433
P1476
A biological profile of a nons ...... ifluoromethylisobutyranilide).
@en
P2093
P304
P356
10.1210/ENDO-91-2-427
P407
P577
1972-08-01T00:00:00Z